AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Hamilton Lane (HLNE)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

155.59

-4.37 (-2.73%)

At close: Feb 20, 2025, 2:05 PM

undefined% (undefined)

Bid	155.19
Market Cap	8.87B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	5.41
PE Ratio (ttm)	28.76
Forward PE	n/a
Analyst	Hold

Ask	155.67
Volume	467,019
Avg. Volume (20D)	485,783
Open	159.72
Previous Close	159.96
Day's Range	152.62 - 159.93
52-Week Range	103.42 - 203.72
Beta	undefined

About HLNE

Hamilton Lane Incorporated is an investment firm specializing in direct and fund of fund investments. It provides following services: separate accounts (customized to each individual client and structured as single client vehicles); specialized strategies (fund-of-funds, secondaries, co-investments, taft-hartley, distribution management); advisory relationships (including due diligence, strategic portfolio planning, monitoring and reporting servi...

[Show more]

Industry Asset Management

Sector Financial Services

IPO Date Mar 1, 2017

Employees 700

Stock Exchange NASDAQ

Ticker Symbol HLNE

Website https://www.hamiltonlane.com

Full Company Profile

Analyst Forecast

According to 6 analyst ratings, the average rating for HLNE stock is "Hold." The 12-month stock price forecast is $175, which is an increase of 12.48% from the latest price.

Buy 0.00%

Hold 83.33%

Sell 16.67%

Stock Forecasts

Next Earnings Release

Hamilton Lane is scheduled to release its earnings on May 22, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-5.89%

Hamilton Lane shares are trading lower after the c... Unlock content with Pro Subscription

2 weeks ago

+5.44%

Hamilton Lane shares are trading higher after Wells Fargo and Keefe, Bruyette & Woods raised their respective price targets on the stock.

News

1 week ago · seekingalpha.com

Hamilton Lane Q3 Earnings: Slowing Momentum, But Shares Remain Expensive

Q3 results showed revenue up 34% year over year, coupled with strong overall profitability, both benefiting from higher incentive fees. Underlying growth in assets under management/advisement was mute...

1 week ago · youtube.com

Market viewing tariffs as negotiating tactic right now, says Hamilton Lane's Hirsch

Erik Hirsch, Hamilton Lane Co-CEO, joins 'Fast Money' to talk the impact of tariffs on the market.

1 week ago · businesswire.com

Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #cosettepharma--Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations.

2 weeks ago · seekingalpha.com

Hamilton Lane Incorporated (HLNE) Q3 2025 Earnings Conference Call Transcript

Hamilton Lane Incorporated (NASDAQ:HLNE ) Q3 2025 Earnings Conference Call February 4, 2025 11:00 AM ET Company Participants John Oh - Head of Shareholder Relations Erik Hirsch - Co-CEO Jeff Armbriste...

2 weeks ago · zacks.com

Hamilton Lane (HLNE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Hamilton Lane (HLNE) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street...

2 weeks ago · zacks.com

Hamilton Lane (HLNE) Tops Q3 Earnings and Revenue Estimates

Hamilton Lane (HLNE) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $0.71 per share a year ago.

2 weeks ago · businesswire.com

Cosette Pharmaceuticals Appoints Brad Leonard as Vice President, Generics Commercial Operation

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #commercial--Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard as Vice President, Generic...

2 months ago · zacks.com

Is the Options Market Predicting a Spike in Hamilton Lane (HLNE) Stock?

Investors need to pay close attention to Hamilton Lane (HLNE) stock based on the movements in the options market lately.